UC Davis Scientist Awarded $1.36M to Develop Angelman Gene Therapy

UC Davis Scientist Awarded $1.36M to Develop Angelman Gene Therapy

305252

UC Davis Scientist Awarded $1.36M to Develop Angelman Gene Therapy

A professor at the University of California (UC) Davis Health has been awarded a $1.36 million Discovery Stage Research Projects (DISC2) grant to develop a gene therapy for Angelman syndrome, according to a university press release. David Segal, PhD, a professor in the departments of biochemistry and molecular medicine, and pharmacology, is also among faculty at the UC Davis Genome Center. The DISC2 grant, from the California Institute for Regenerative Medicine (CIRM) and funded through The…

You must be logged in to read/download the full post.